Shaoping Tang – Trademark Portfolio
Entity Type: 01
Shaoping Tang owns a portfolio of 23 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as GEXHG, GHEWO, GJIAW, HCYNA, and HLGHD. Of these, 23 are registered. The portfolio spans 13 Nice Classification classes, led by Class 18 (Leather Goods) and Class 24 (Fabrics). Headquartered in Guangzhou.
Room 2502, No. 161,
Tianfu Road, Tianhe District,
Guangzhou 510630 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shaoping Tang's trademark portfolio spans 13 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Shaoping Tang have?
Shaoping Tang has 23 U.S. trademarks filed with the USPTO. Of these, 23 registered.
What trademark classes does Shaoping Tang file in?
Shaoping Tang files trademarks across 13 Nice Classification classes. The most active classes are Class 18 (Leather Goods), Class 24 (Fabrics), Class 10 (Medical Apparatus), Class 25 (Clothing), Class 3 (Cosmetics & Cleaning). Class 18 covers leather and imitations of leather; animal skins, hides; trunks and travelling bags.
What are Shaoping Tang's most well-known trademarks?
Shaoping Tang's registered trademark portfolio includes well-known marks such as GEXHG, GHEWO, GJIAW, HCYNA, and HLGHD. These are among 23 currently registered trademarks in the portfolio.
What is Shaoping Tang's trademark registration success rate?
Shaoping Tang has a 100% trademark registration rate, with 23 out of 23 resolved applications resulting in successful registration. Currently, 0 applications are pending review.